The Clinical Effect Of Sanju Kechuan Oral Liquid In The Treatment Of Acute Pulmonary Heart Disease With Respiratory Failure

Purpose: 1.To evaluate the clinical efficacy of sanju kechuan oral liquid in the treatment of pulmonary heart disease combined with respiratory failure in the acute episode,and to provide valuable theoretical and clinical data support for the promotion of sanju kechuan oral liquid.2.Summarize the experience of professor zhang xiaoyun in the treatment of pulmonary heart disease with traditional Chinese medicine,and summarize the experience of combining traditional Chinese and western medicine in the treatment of acute pulmonary heart disease,so as to provide reference academic experience for the clinical treatment of pulmonary heart disease.Methods: 1.Clinical research 69(64 cases)subjects were randomly divided into control group and experimental group by the method of generating random Numbers by Excel.The baseline and baseline conditions of the two groups of subjects were compared to ensure that the baseline level of subjects was consistent.The control group received conventional western medicine treatment,the experimental group in the control group on the basis of the addition of sanju cough and asthma oral liquid,continuous observation for 14 days.Before treatment,the total score of TCM syndrome and blood gas analysis were observed on the 7th and 14 th days of treatment respectively.Data were collected and processed with SPSS 21.0 software,and the efficacy and safety of sanju kechuan oral liquid were evaluated.2.To summarize the clinical experience of combined traditional Chinese and western medicine in the treatment of pulmonary heart disease 3.Summarize professor zhang xiaoyun's clinical experience in the treatment of pulmonary heart disease.Results:1.Clinical research Comparison of total efficacy: control group: the total effective rate was 68.8% and the penetrance rate was 12.5%.Experimental group: the total effective rate was 87.5% and the penetrance rate was 40.6%.In terms of clinical efficacy,the statistical difference between the control group and the experimental group was statistically significant,and the experimental group was superior to the control group.Comparison of TCM symptoms and signs and total sputum scores: the experimental group was better than the control group,and the difference was statistically significant.The score of secondary symptoms was statistically significant before treatment,so the difference of the score of secondary symptoms(before treatment and after treatment)was statistically significant,and the experimental group was superior to the control group.Comparison of lung function: after 14 days of treatment,FEV1/FVC showed statistical difference between the two groups,and the experimental group was better than the control group.After treatment,the expected percentage of FEV1 showed no statistical difference between the groups,and the experimental group was not superior to the control group.Comparison of blood gas analysis: compared with the control group,the measured Pa O2 and Pa O2 in the experimental group showed statistically significant differences,and the experimental group was superior to the control group.Comparison of inflammatory indicators: the c-reactive protein levels of the two groups were compared,and the difference was statistically significant.The experimental group was superior to the control group.Nutritional indicators,electrolyte level comparison: the experimental group and the control group,the differences are statistically significant,the experimental group is better than the control group.2.Experience of integrated Chinese and western medicine in the treatment of pulmonary heart disease Chinese medicine full participation,clear the airway,careful use of diuretics,cardiac tonic.3.Professor zhang xiaoyun's experience in the treatment of pulmonary heart disease The unity of man and nature,three factors;Combination of disease differentiation and syndrome differentiation.Conclusion: 1.Both treatment regimens of the two groups showed effectiveness in this clinical study,but the efficacy of the experimental group was better than that of the control group.2.Sanju kechuan oral liquid has a positive efficacy and high safety in the treatment of pulmonary heart disease in acute attack period with respiratory failure.